User profiles for Nur Syafinaz Zainal
 | nur syafinaz zainalPostgraduate Student, University of Southampton UK Verified email at soton.ac.uk Cited by 137 |
[HTML][HTML] Monitoring T cells responses mounted by therapeutic cancer vaccines
With the regulatory approval of Provenge and Talimogene laherparepvec (T-VEC) for the
treatment of metastatic prostate cancer and advanced melanoma respectively, and other …
treatment of metastatic prostate cancer and advanced melanoma respectively, and other …
Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells
… Author links open overlay panel Nur Syafinaz Zainal a , Chai Phei Gan a , Beng Fye Lau b
, Pei San Yee a , Kai Hung Tiong a c , Zainal Ariff Abdul Rahman c d , Vyomesh Patel a , Sok …
, Pei San Yee a , Kai Hung Tiong a c , Zainal Ariff Abdul Rahman c d , Vyomesh Patel a , Sok …
[HTML][HTML] Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
Objective Lack of effective therapies remains a problem in the treatment of oral squamous
cell carcinoma (OSCC), especially in patients with advanced tumors. OSCC development is …
cell carcinoma (OSCC), especially in patients with advanced tumors. OSCC development is …
IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells
Purpose Oral squamous cell carcinoma (OSCC) is a challenging disease to treat. Up to 50%
of OSCC patients with advanced disease develop recurrences. Elucidation of key molecular …
of OSCC patients with advanced disease develop recurrences. Elucidation of key molecular …
DNA Vaccines targeting novel cancer-associated antigens frequently expressed in head and neck cancer enhance the efficacy of checkpoint inhibitor
C Wang, NS Zainal, SJ Chai, J Dickie, CP Gan… - Frontiers in …, 2021 - frontiersin.org
HPV-independent head and neck squamous cell carcinoma (HNSCC) is a common cancer
globally. The overall response rate to anti-PD1 checkpoint inhibitors (CPIs) in HNSCC is ~16…
globally. The overall response rate to anti-PD1 checkpoint inhibitors (CPIs) in HNSCC is ~16…
Synergistic growth inhibition by afatinib and trametinib in preclinical oral squamous cell carcinoma models
Background Given that aberrant activation of epidermal growth factor receptor family receptors
(ErbB) is a common event in oral squamous cell carcinoma, and that high expression of …
(ErbB) is a common event in oral squamous cell carcinoma, and that high expression of …
The 4717C> G polymorphism in periplakin modulates sensitivity to EGFR inhibitors
The use of EGFR inhibitors on oral squamous cell carcinoma (OSCC) as monotherapy yielded
modest clinical outcomes and therefore would benefit from biomarkers that could predict …
modest clinical outcomes and therefore would benefit from biomarkers that could predict …
Resistance to dasatinib is associated with the activation of Akt in oral squamous cell carcinoma
Objectives: Overexpression and aberrant activation of Src promote the development of oral
squamous cell carcinoma (OSCC), thus therapies targeting Src-related kinases may afford an …
squamous cell carcinoma (OSCC), thus therapies targeting Src-related kinases may afford an …
[PDF][PDF] Purchasing counterfeit mobile accessories among millennials
NH Hashim, NBM Zainal, NI Syafinaz… - Malaysian Journal of …, 2020 - majcafe.com
Counterfeiting is an emerging issue that affects the economy, businesses, and consumers
worldwide. This study focuses on factors such as price, ethical concern, and social influence …
worldwide. This study focuses on factors such as price, ethical concern, and social influence …
Evaluation of palbociclib in oral squamous cell carcinoma and the role of PIK3CA in conferring resistance/Nur Syafinaz Zainal
Z Nur Syafinaz - 2019 - studentsrepo.um.edu.my
Lack of effective therapies remains a problem in the treatment of oral squamous cell carcinoma
(OSCC), especially in patients with advanced tumors. OSCC development is driven by …
(OSCC), especially in patients with advanced tumors. OSCC development is driven by …
